Related Experiment Video
Updated: Feb 1, 2026

Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
Interactions of mannose binding-lectin with red blood cells by employing cationic quantum dots
Carinna N Lima1, Paulo E Cabral Filho2, Beate S Santos3
1Departamento de Biofísica e Radiobiologia, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil; Instituto de Ciências Biológicas, Universidade de Pernambuco, Recife, Pernambuco, Brazil.
Abstract:
Mannose-binding lectin (MBL) plays important roles by interacting with specific molecular patterns on cell surfaces, triggering first-line host defense. We investigated the MBL interaction with healthy red blood cell membranes as well as its effects on the membrane rheology. We explored electrostatic interactions between cationic quantum dots (QDs) and negatively charged red blood cell surfaces to quantitatively evaluate membrane electrical charges as well as to investigate the MBL binding to healthy erythrocytes. Results showed that cationic QDs labeled efficiently red blood cells. However, the MBL interaction with erythrocytes prevents the QD labeling. We also observed that red blood cells treated with MBL are more resistant to lysis, suggesting a membrane-stabilizing effect. Moreover, we used a fluorescent anti-MBL antibody and Candida albicans cells to further study the MBL interaction with erythrocytes. Our results of this comparative labeling suggested that either this probe was not effective to detect MBL bound to healthy red blood cells (by its carbohydrate-recognition domain) or the MBL binding to those cells might be occurring via another portion. Thus, our results demonstrated the ability of MBL interacting with healthy red blood cells and pointed out to a new role of this protein as a membrane-stabilizing molecule.
Related Concept Videos
Quantum Numbers
The Quantum-Mechanical Model of an Atom
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
The Equilibrium Binding Constant and Binding Strength
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

